GSK (GSK) P/E (2007 - 2026)
GSK (GSK) P/E from Jul 2, 2007 to Jul 20, 2026. The TTM GSK (GSK) P/E is 11.78. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of GSK (GSK)
| Year | P/E | Change |
|---|---|---|
| 2026 | 11.78 | -0.68% |
| 2025 | 11.86 | -44.96% |
| 2024 | 21.54 | +110.86% |
| 2023 | 10.22 | +134.64% |
| 2022 | 4.35 | -75.56% |
| 2021 | 17.81 | +40.16% |
| 2020 | 12.71 | -35.84% |
| 2019 | 19.81 | -0.90% |
| 2018 | 19.99 | -31.36% |
| 2017 | 29.12 | -89.45% |
| 2016 | 276.00 | +3421.96% |
| 2015 | 7.84 | -66.15% |
| 2014 | 23.15 | +54.26% |
| 2013 | 15.01 | +0.07% |
| 2012 | 15.00 | -31.95% |
| 2011 | 22.04 | -44.78% |
| 2010 | 39.91 | +224.49% |
| 2009 | 12.30 | +6.48% |
| 2008 | 11.55 | -38.65% |
| 2007 | 18.83 | N/A |
Comparison GSK (GSK) P/E with competitors
GSK (GSK) P/E is 11.78.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -14.15% |
| PFE | Pfizer Inc | 11.65 | -1.03% |
| NVO | Novo Nordisk | 11.79 | +0.13% |
| SNY | Sanofi | 12.12 | +2.96% |
| BMY | Bristol-Myers Squibb Company | 13.82 | +17.36% |
| OGN | Organon & Company | 14.33 | +21.67% |
| BIIB | Biogen Inc | 17.41 | +47.81% |
| GILD | Gilead Sciences Inc | 17.75 | +50.69% |
| NVS | Novartis AG | 21.60 | +83.40% |
| JNJ | Johnson & Johnson | 22.09 | +87.57% |
| AMGN | AMGEN Inc | 24.75 | +110.19% |
| MRK | Merck & Co Inc | 26.93 | +128.67% |
| AZN | Astrazeneca plc | 28.44 | +141.54% |
| LLY | Lilly(Eli) & Company | 48.44 | +311.39% |
| ABBV | Abbvie Inc | 139.08 | +1081.09% |